William Coley
The Hospital for the Ruptured and Crippled: William Bradley Coley, Third Surgeon-in-Chief 1925–1933
Rootsweb:
Child of Horace Bradley Coley and Clarinda Bradley Wakeman
http://wc.rootsweb.ancestry.com/cgi-bin/igm.cgi?op=GET&db=geolarson2&id=I230266
William Bradley Coley was born 1862 in Westport, Connecticut, USA, and died 1936 in New York, New York, USA.
Wikipedia:
William Bradley Coley (January 12, 1862 Westfield, Connecticut - April 16, 1936) was an American bone surgeon and cancer researcher, pioneer of cancer immunotherapy. He developed a treatment based on provoking an immune response to bacteria. In 1968 a protein related to his work was identified and called tumor necrosis factor alpha.
He was born on January 12, 1862 in Westfield, Connecticut to Horace Bradley Coley and Clarina B. Wakeman.
He began his career as a bone surgeon at New York Cancer Hospital (which later became part of the Memorial Sloan-Kettering Cancer Center); however, he became more interested in cancer treatment when one of his early patients died from bone cancer. While going through hospital records, Coley found a sarcoma case study of one patient named Fred Stein, whose tumor disappeared following a high fever from erysipelas infection, now known as Streptococcus pyogenes. This sparked Coley's interest and drove him to find what few examples of similar cancer treatment had been previously recorded. He discovered that other medical pioneers including Robert Koch, Louis Pasteur, and Emil von Behring, had recorded observations of erysipelas infection coinciding with cancer regression.
Coley's first intentional erysipelas infection was performed on a patient named Mr. Zola on May 3, 1891, who had tonsil and throat cancer. Mr. Zola came down with erysipelas and his condition improved tremendously. Mr. Zola lived for another eight and a half years.
Coley was convinced that he could effectively use bacteria to treat cancer and created a mixture of killed bacterial infusions called Coley's Toxins. The infusion was administered by injection in increasing doses to induce a fever. Once stimulated, he observed, the immune system could be capable of tackling cancerous cells along with the infection. The cancerous cells would then slough off.
The infusions of killed bacteria are now known as Coley's Toxins. They are currently available to patients suffering from cancer in a variety of countries. One reformulation of Coley's Toxins persists under the name Coley Fluid
Coley developed the theory that it was the infections which had helped patients in the past to recover from their cancer. So he began to treat patients by injecting a brew of Streptococcus pyogenes directly into inoperable tumors. This met with much success, even after metastasis.[citation needed] The treatment was most effective when it provoked a fever and a full-blown infection. This observations coincided with similar observations in 1867 by the German physician W. Busch when his patient's tumor became smaller after a high fever. Later, Coley decided to use a mixture of dead Streptococcus pyogenes and dead Serratia marcescens bacteria. According to Stephen Hoption Cann of the University of British Columbia, "He had successes you simply couldn't hope for today, curing even extensive metastatic disease."
On January 24, 1893, the first patient to receive Coley Vaccine was John Ficken, a sixteen-year-old boy with a massive abdominal tumor. Every few days, Coley injected his vaccine directly into the tumor mass and produced the symptoms of an infectious disease, but did not produce the disease itself. On each injection, there was a dramatic rise in body temperature and chills. The tumour gradually diminished in size. By May 1893, after four months of intensive treatment, the tumour was a fifth its original size. By August, the remains of the growth were barely perceptible.
The boy received no further anticancer treatment and remained in good health until he died of a heart attack 26 years later. Coley published his results and by the turn of the century 42 physicians from Europe and North America had reported cases of cancer that had been successfully treated with Coley Vaccine.
Drug makers including Pfizer and Sanofi-Aventis also have a renewed interest in modern versions of Coley's Toxins.
The historical results of Coley Vaccine therapy are difficult to compare with modern results. Coley's studies were not well controlled and factors such as length of treatment and fever level were not adequately documented. Many of his patients had also received radiation and sometimes surgery. According to the analyses of Coley Nauts and Starnes, treatment success correlated with length of therapy and the fevers induced by the toxins. The recently formed non-profit Global Cures Foundation plans to fund research trials of Coley's Toxins in the near future.
There were, however, many different formulations of Coley Vaccine. These varied greatly in effectiveness, and there were many different treatment protocols that also varied greatly in effectiveness.
Received October 31, 2007; Accepted October 31, 2007.
In January 1925, the Board of Managers of the New York Society for the Relief of the Ruptured and Crippled appointed William Bradley Coley, M.D., age 63, Surgeon-in-Chief of the Hospital for the Ruptured and Crippled (R & C) to succeed Virgil P. Gibney who submitted his resignation the month before. It would be the first time a general surgeon held that position at the oldest orthopedic hospital in the nation, now known as Hospital for Special Surgery (HSS). Coley had been on staff for 36 years and was world famous for introducing use of toxins to treat malignant tumors, particularly sarcomas. A graduate of Yale College and Harvard Medical College, Coley interned at New York Hospital and was appointed, soon after, to the staff of the New York Cancer Hospital (now Memorial Sloan Kettering Cancer Center) located at that time at 106th Street on the West Side of New York. With his mentor Dr. William Bull, Coley perfected the surgical treatment of hernias at R & C. He was instrumental in raising funds for his alma maters, Yale, Harvard and Memorial Hospital. His crusade in immunology as a method of treatment for malignant tumors later fell out of acceptance in the medical establishment. After his death in 1936, an attempt to revive interest in use of immunotherapy for inoperable malignancies was carried out by his daughter, Helen Coley Nauts, who pursued this objective until her death at age 93 in 2000. Coley's health deteriorated in his later years, and in 1933, he resigned as chief of Bone Tumors at Memorial Hospital and Surgeon-in-Chief at R & C, being succeeded at Ruptured and Crippled as Surgeon-in-Chief by Dr. Eugene H. Pool. William Bradley Coley died of intestinal infarction in 1936 and was buried in Sharon, Connecticut.
Key words: Virgil P. Gibney, William Bradley Coley, Hospital for the Ruptured and Crippled (R & C), New York Hospital, Hospital for Special Surgery (HSS), Lewis Clark Wagner, William T. Bull, Bessie Dashiell, John D. Rockefeller, Jr, New York Cancer Hospital, Royal Whitman, Bradley L. Coley, Bradley L. Coley, Jr, Helen Coley Nauts, Joseph D. Flick
Gibney is dead. One of the fathers of Orthopaedic Surgery has been called away. The world is poorer by his loss!….Dr.Gibney is dead, but his memory liveth and will live because he was more than a surgeon. He was a man with greatness in him. [4]
William Bradley Coley was appointed clinical assistant to the Hernia Clinic in 1889 just 1 year after receiving his medical degree from Harvard Medical School and while a house surgeon at the New York Hospital (Fig. 1). It was Dr. William T. Bull (1849–1909), an eminent surgeon at the New York Hospital and Attending Surgeon of the Hernia Department at R & C, who took a liking to Dr. Coley and arranged his appointment as well as at other prestigious institutions. Bull was a close colleague of Gibney and shared an office with him [5].
Born in the small village of Saugatuck, outside Westport, on the Connecticut shoreline of the Long Island Sound on January 12, 1862, William B. Coley was the first surviving son of Horace Bradley Coley and Clarina Wakeman Coley. The family came from a long lineage of farmers, schoolmasters, and religious leaders from West of England dating back into the early part of the seventeenth century. It was the beginning of the second year of the Civil War and the year before the founding of the Hospital for the Ruptured and Crippled in 1863.
Helen Coley Nauts - William Coley's daughter and founder of the Cancer Research Institute.
On September 2, 1907, Alice Coley gave birth to Helen Lancaster Coley in Sharon, Connecticut. Although she would have no medical training, Helen Coley would become a major figure in her father's legacy of Coley's toxins. Married to a banker, William Nauts, and raising two children, Helen Coley Nauts, at age 29, organized and researched, after his death, all of his medical records and case histories stacked away in their Sharon barn.
Luckily for Coley, in his first years as Surgeon-in-Chief, the era of the roaring twenties did not spill over into hospital routine. The hospital administrator, Joseph Flick, now in his eighth year, relieved a great deal of burden from the Surgeon-in-Chief's administrative duties, a welcome change from the time Gibney had assumed that office. Flick was a very able organizer, very congenial with the professional staff, and well liked by everyone.
- Dr. Samuel Kleinberg—scoliosis
- Dr. Arthur Krida—congenital dislocation of the hip
- Dr. Paul Colonna—hip reconstruction
- Dr. Toufick Nicola—recurrent dislocation of the shoulder
- Dr. Lewis Clark Wagner—paralytic drop foot.
.
Probably his most prestigious honor had come in October 1935 when he reported a large number of 5-year survivals of inoperable malignant tumors, treated with his toxins, at the Royal College of Surgeons of England where he was inducted as an honorary fellow (the fifth American so honored) in that distinguished society [16].
In 1933, the Board of Managers appointed Dr. Eugene Hillhouse Pool, Coley's successor, as the fourth Surgeon-in Chief at R & C. Pool, director of one of the two surgical services at New York Hospital, President of the New York Academy of Medicine and President-elect of the American College of Surgeons had been an associate of Dr. William Bull.
Footnotes
No comments:
Post a Comment